Whilst the heart rate increases observed were statistically significant, they were not associated with a higher rate of serious adverse cardiac events in the Phase 2 data
Srivastava KD, Bardina L, Sampson H, Li X-M
From mechanisms to medicine: ferroptosis as a therapeutic target in liver disorders
Our study highlighted two major findings
Our mission is to facilitate affordable access to tirzepatide through comprehensive insurance support: Coverage Details: Whether insured with United Healthcare, Blue Cross Blue Shield, Cigna, Medicare, or Medicaid, coverage for tirzepatide varies
He was conscious, afebrile but dehydrated with a heart rate of 105 bpm, blood pressure 110/60 mmHg and exhibited Kussmaul respiration